LEXX – lexaria bioscience corp. (US:NASDAQ)
Stock Stats
News
Lexaria Bioscience (LEXX) was upgraded by Weiss Ratings from "sell (e+)" to "sell (d-)".
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales [Yahoo! Finance]
Lexaria Bioscience (NASDAQ:LEXX) Will Have To Spend Its Cash Wisely [Yahoo! Finance]
Lexaria's Robust Patent Portfolio Continues to Grow [Yahoo! Finance]
Form 10-Q Lexaria Bioscience Corp. For: Feb 28
Form 4 Lexaria Bioscience Corp. For: Mar 17 Filed by: BUNKA CHRISTOPHER
Form 8-K Lexaria Bioscience Corp. For: Feb 04
Form 8-K Lexaria Bioscience Corp. For: Jan 27
Form S-8 Lexaria Bioscience Corp.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.